AI assistant
RESMED INC — Earnings Release 2020
Jan 9, 2020
65715_rns_2020-01-09_5878ed74-c115-4c1d-9b52-bc3055e042c8.pdf
Earnings Release
Open in viewerOpens in your device viewer
==> picture [101 x 80] intentionally omitted <==
For investors For media Amy Wakeham Jayme Rubenstein +1 858.836.5000 +1 858.836.6798 [email protected] [email protected]
ResMed to Report Second Quarter Fiscal 2020 Earnings on January 30, 2020
SAN DIEGO, January 9, 2020 – ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2020 on Thursday, January 30, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.
Earnings webcast details:
| | Location: | http://investor.resmed.com |
|---|---|---|
| | Date: | Thursday, January 30, 2020 |
| | Time: | 1:30 p.m. PT / 4:30 p.m. ET |
| | International: | London, Thursday, January 30, 9:30 p.m. |
| Sydney, Friday, January 31, 8:30 a.m. |
Please note that ResMed does not use outside phone lines to access the earnings call.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from January 30 until February 13 at:
-
U.S.: +1 800.585.8367
-
International: +1 416.621.4642
-
Passcode: 8829576
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.